Lista de obras - Guangfu Li - Dominio Público Uruguay

A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer.

artículo científico publicado en 2016

ATF5 Connects the Pericentriolar Materials to the Proximal End of the Mother Centriole

artículo científico publicado en 2015

BCL-2 Is a Downstream Target of ATF5 That Mediates the Prosurvival Function of ATF5 in a Cell Type-dependent Manner ⬇️

artículo científico publicado el 6 de enero de 2011

Characterization of CD4+ T cell responses in mice infected with Schistosoma japonicum

artículo científico publicado en 2006

Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques

artículo científico publicado en 2015

Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.

artículo científico publicado en 2015

Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients

scientific article published on 23 October 2013

Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer.

artículo científico publicado en 2015

Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer.

artículo científico publicado en 2016

Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent

artículo científico publicado en 2015

Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis.

artículo científico publicado en 2017

HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation

scientific journal article

Identification of immunodominant Th1-type T cell epitopes from Schistosoma japonicum 28 kDa glutathione-S-transferase, a vaccine candidate.

artículo científico publicado en 2005

Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma

artículo científico publicado en 2015

MAPK-activated protein kinase 2 differentially regulates plasmodium falciparum glycosylphosphatidylinositol-induced production of tumor necrosis factor-{alpha} and interleukin-12 in macrophages

artículo científico publicado en 2009

Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice

artículo científico publicado en 2018

Nanolock-Nanopore Facilitated Digital Diagnostics of Cancer Driver Mutation in Tumor Tissue.

artículo científico publicado en 2017

Perioperative circulating tumor cell detection: Current perspectives

artículo científico publicado en 2016

Potential of Radiofrequency Ablation in Combination with Immunotherapy in the Treatment of Hepatocellular Carcinoma

scientific article published on 05 April 2016

Preliminary identification of T cell epitopes on 22.6 kDa antigen of Schistosoma japonicum

artículo científico publicado en 2003

Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum are mainly mediated through the recognition of TLR2/TLR1

artículo científico publicado en 2011

Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.

artículo científico publicado en 2012

Studies on the characteristic of interferon-gamma mediating resistance in mice infected with Schistosoma japonicum

artículo científico publicado en 2004

Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model

artículo científico publicado en 2016

Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer.

artículo científico publicado en 2017

Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response

scientific article published on 01 October 2020

Targeted and Immune-based Therapies for Hepatocellular Carcinoma

scientific article published on 01 October 2018

What is the potential of nanolock- and nanocross-nanopore technology in cancer diagnosis?

artículo científico publicado en 2017

Lista de obras de Guangfu Li

A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer.

ATF5 Connects the Pericentriolar Materials to the Proximal End of the Mother Centriole

BCL-2 Is a Downstream Target of ATF5 That Mediates the Prosurvival Function of ATF5 in a Cell Type-dependent Manner ⬇️

Characterization of CD4+ T cell responses in mice infected with Schistosoma japonicum

Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques

Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.

Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients

Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer.

Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer.

Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent

Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis.

HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation

Identification of immunodominant Th1-type T cell epitopes from Schistosoma japonicum 28 kDa glutathione-S-transferase, a vaccine candidate.

Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma

MAPK-activated protein kinase 2 differentially regulates plasmodium falciparum glycosylphosphatidylinositol-induced production of tumor necrosis factor-{alpha} and interleukin-12 in macrophages

Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice

Nanolock-Nanopore Facilitated Digital Diagnostics of Cancer Driver Mutation in Tumor Tissue.

Perioperative circulating tumor cell detection: Current perspectives

Potential of Radiofrequency Ablation in Combination with Immunotherapy in the Treatment of Hepatocellular Carcinoma

Preliminary identification of T cell epitopes on 22.6 kDa antigen of Schistosoma japonicum

Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum are mainly mediated through the recognition of TLR2/TLR1

Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.

Studies on the characteristic of interferon-gamma mediating resistance in mice infected with Schistosoma japonicum

Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model

Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer.

Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response

Targeted and Immune-based Therapies for Hepatocellular Carcinoma

What is the potential of nanolock- and nanocross-nanopore technology in cancer diagnosis?